Precision of a phage susceptibility spot assay assessed with 154 clinical Staphylococcus aureus isolates

Sebastian C Herren1, Christoph L Zink1, Jay Mandrekar2

  • 1Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

Microbiology Spectrum
|March 3, 2026
PubMed

Insights

A novel spot assay precisely measures staphylococcal phage K susceptibility in Staphylococcus aureus isolates. This method shows high repeatability, supporting phage therapy

Area of Science:

  • Microbiology
  • Bacteriology
  • Phage Therapy

Background:

  • Recalcitrant bacterial infections necessitate novel therapeutic strategies.
  • Bacteriophages (phages) offer a promising alternative to antibiotics.
  • Standardized methods for phage susceptibility testing are crucial for clinical application.

Purpose of the Study:

  • To evaluate the precision and repeatability of a double overlay spot assay for assessing staphylococcal phage K susceptibility.
  • To determine the infectivity of phage K against Staphylococcus aureus isolates from periprosthetic joint infections.

Main Methods:

  • A double overlay spot assay was employed to test staphylococcal phage K against 154 Staphylococcus aureus isolates.
  • Assays were performed in technical and biological triplicates.
  • Plaque morphology was scored (0-4), and plaque-forming unit per milliliter (PFU/mL) titers were determined.

Main Results:

  • The assay demonstrated high intermediate precision (inter-day coefficient of variation: 2.5) and repeatability (intra-day coefficient of variation: 0.9).
  • 107 out of 154 isolates (69.5%) showed significant susceptibility to phage K (morphology score ≥2).
  • Plaque-forming unit per milliliter titers strongly correlated with morphology scores (Spearman's ρ = 0.8, P < 0.0001).

Conclusions:

  • The described double overlay spot assay exhibits high precision and repeatability for assessing Staphylococcus aureus susceptibility to staphylococcal phage K.
  • This standardized method is suitable for routine laboratory testing and supports the clinical implementation of phage therapy.